|
Salmonella typhi (Typhoid Fever) and
S.
paratyphi (Paratyphoid Fever)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1:
Extra-Intestinal Infectious Complications of
Typhoid Fever Caused by Salmonella enterica serotype Typhi
Table 2:
Minimum Inhibitory Concentrations (μg/ml) for
Selected Antibiotics Against Salmonella typhi
Table 3: Fluoroquinolone
Efficacy in Enteric Fever
Table 4:
Third Generation Cephalosporin Efficacy In Enteric
Fever
Table 5: Azithromycin
Efficacy In Enteric Fever
Table 6:
Antibiotics of Choice
Table 7:
Typhoid Vaccines
Figure 1:
1,000 Cases per
100,000 Population per Year.
Vignettes
Review Article:
Huang DB, DuPont HL. Problem pathogens: extra-intestinal complications of
Salmonella enterica serotype Typhi infection. Lancet Infect Dis 2005;5:341-8.
Lin-Hui Su and
Cheng-Hsun Chiu:
Nomenclature of Salmonella.
Review Article: Connor BA, Schwartz
E. Typhoid and paratyphoid fever in travellers. Lancet Infectious
Diseases 2005;5:623-628.
Chau TT, Campbell JJ, et al.
Antimicrobial Drug Resistance of Salmonella enterica
Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the
Fluoroquinolones. Antimicrob Agents Chemother 2007;51(12):
4315-4323.
Gupta
et. al.
Laboratory-based Surveillance of Paratyphoid Fever in
the United States: Travel and Antimicrobial Resistance.
Clin Infect Dis.
2008 Jun 1;46(11):1656-63.
Sur D, et al.
A Cluster-Randomization Effectiveness Trial of Vi
Typhoid Vaccine in India. New Engl J Med
2009;361(4):335-344.
Levine MM.
Typhoid Vaccines Ready for Implementation: A History.
New Engl J Med 2009;361(4):403-405.
Lynch MF, et al.
Typhoid
fever in the United States, 1999-2006.
JAMA
2009;302(8):859-65.
Authors
David Huang, M.D., Ph.D., MPH,
Nicholas J. White,
M.D., ,Herbert L. DuPont,
MD
|
www.antimicrobe.org